Qingdao Saber Technology Pharmaceutical (revision 16)
Old revision·19:49, 5 Aug 2025·DrTitration
| Qingdao Saber Technology Pharmaceutical | |
|---|---|
Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| Legal name | Qingdao Saber Technology Pharmaceutical |
| Trading name | QST |
| Other designations | QST Biotech, Qingdao Saber Technology Pharmaceutical |
| Identity | |
| Founded | 2017 |
| Headquarters | Qingdao, China |
| Industry | Research-compound supply |
| Shop domain | Visit QST |
| Organisation infobox · conventions | |
Qingdao Saber Technology Pharmaceutical (trading as QST; qingdaosabertechnology.com) is a research-compound supplier trading as QST from Qingdao, Shandong, China, incorporated in 2017, supplying research peptides, SARMs and raw materials with batch documentation.[1][2]
The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]Incorporated in 2017 in Qingdao, the organisation is one of two covered here based in that city, the other being Qingdao Sigma Chemical.[1] Qingdao has a substantial chemical and pharmaceutical-intermediate sector and a major port, which is the extent of what can reliably be said about the industrial context.
Its registered name includes "Pharmaceutical", which places the registration closer to its trading activity than several comparators. That is a registry fact and not an indication of regulatory status: registration in a pharmaceutical business scope is not a manufacturing authorisation and confers no quality assurance.[1]
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
Operations and documentation practice
[edit]Purchaser reports describe lyophilised material in crimped vials with a batch certificate reporting purity and appearance. Water figures have appeared inconsistently across the submitted set.[5] Packaging descriptions have been conventional, with a gel pack on the temperature-sensitive lines.
No certification claim has been corroborated, and the organisation's own statements about capability are self-published.[2][6]
References
- ^ a b c National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ a b Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.
- ^ World Health Organization, Good Manufacturing Practices for Pharmaceutical Products: Main Principles, WHO Technical Report Series. The general framework against which a GMP claim is assessed.